Home/Publication/Qiming, Yunfeng & Hony to Conclude Investment in LaNova Medicines
Qiming, Yunfeng & Hony to Conclude Investment in LaNova Medicines 

16 Jul 2025

US$ 20.00

Qiming Venture Partners, Yunfeng Capital, Hony Capital, and BioTrack Capital are among the investors selling an ......

Price / article: US$20.00
OR existing subscriber
Related Publications

US-based Volition Capital has led the US$15 m series B funding round of adtech startup Linkby Pty Ltd (Linkby). The ......

Mizuho Capital, Nissay Capital, Keio Innovation Initiative and SBI Investment were party to the ¥2.3 bn (US$15.7 m) ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.